* CytoDyn (OTCQB:CYDY [https://seekingalpha.com/symbol/CYDY]) obtained a $30M funding commitment [https://seekingalpha.com/pr/20289715-cytodyn-secures-30-million-commitment-from-yorkville-advisors] from Yorkville Advisors Global.
* The agreement allows CytoDyn to sell up to $30M in common stock to Yorkville over the next 36 months.
* Funds will support ongoing development of leronlimab for triple-negative breast cancer and metastatic colorectal cancer.
MORE ON CYTODYN
* Seeking Alpha’s Quant Rating on CytoDyn [https://seekingalpha.com/symbol/CYDY/ratings/quant-ratings]
* Financial information for CytoDyn [https://seekingalpha.com/symbol/CYDY/income-statement]
CytoDyn secures $30M equity funding commitment
Published 6 days ago
Nov 3, 2025 at 1:41 PM
Neutral
Auto